Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Virginia Commonwealth University Medical Center (formerly known as Medical College of Virginia), Richmond, Virginia, United States
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
University of Alabama at Birmingham, Birmingham, Alabama, United States
Cooper University Hospital, Camden, New Jersey, United States
Centre Valaisan de Pneumologie, Montana, Switzerland
BC Children's Hospital, Department of Anesthesia, Vancouver, British Columbia, Canada
Azienda Ospedaliera San Gerardo, Monza, Italy
Azienda Ospedaliera di Padova, Padova, Italy
Vita-Salute University, Milano, Italy
Azienda Ospedaliera di Perugia (H Santa Maria della Misericordia), Perugia, Italy
Department of Neonatology of Julia Kubitschek Hospital, Belo Horizonte, Minas Gerais, Brazil
Fundação Centro Médico de Campinas, Campinas, São Paulo, Brazil
Cooper University Hospital, Camden, New Jersey, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.